|
Cours en clôture
Shanghai S.E.
31/07/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
18,85 CNY
|
-1,46%
|
 |
+2,45%
|
+6,98%
|
|
24/04 |
Dashenlin Pharma's Q1 Profit Rises 11%
| | |
24/04 |
Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4%
| | |
23/04 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
23/04 |
Dashenlin pharmaceutical 2025 net profit up 35.0% y/y
| | |
23/04 |
Sipai Health to Sell Stake in Pharmacy Operator to Dashenlin Pharmaceutical For RMB 51.7 Million
| | |
22/04 |
DaShenLin Pharmaceutical Group Co., Ltd. signed a equity transfer agreement to acquire Sipai Zhihe Technology Co., Ltd. from Sipai Healthcare Investment Group Co., Ltd. for CNY 79.1 million.
| | |
29/10/25 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
28/08/25 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
25/04/25 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
25/04/25 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
| | |
15/10/24 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
| | |
20/09/24 |
Tranche Update on DaShenLin Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 7, 2024.
| | |
18/09/24 |
DaShenLin Pharmaceutical Group Co., Ltd.'s Equity Buyback announced on May 7, 2024, has closed with 6,722,254 shares, representing 0.59% for CNY 100.72 million.
| | |
30/08/24 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
| | |
03/07/24 |
Tranche Update on DaShenLin Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 7, 2024.
| | |
07/05/24 |
DaShenLin Pharmaceutical Group Co., Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on April 1, 2024.
| | |
28/04/24 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
| | |
28/04/24 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
| | |
18/03/24 |
Dashenlin Pharmaceutical to Buy Back Up to 200 Million Yuan Shares
| | |
05/03/24 |
Dashenlin Pharmaceutical Plans to Buy Back Up to 200 Million Yuan Worth of Shares
| | |
23/01/24 |
DaShenLin Pharmaceutical Group Co., Ltd. cancelled the transaction announced on January 19, 2023
| | |
27/11/23 |
Dashenlin Pharmaceutical to Boost Stake in Local Pharmacy Chain to 66% For 30 Million Yuan
| | |
25/11/23 |
DaShenLin Pharmaceutical Group Co., Ltd. agreed to acquire 15% stake in Chongqing Wanjiayan Pharmacy Chain Co., Ltd from Chongqing Wanjiayan Health Industry Group Co., Ltd. and Bai Run for CNY 30 million.
| | |
30/10/23 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
| | |
29/08/23 |
DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
